CrossAmerica Partners LP CAPL Q1 2026 Earnings Massive EPS Beat Despite Revenue Uncertainty Halozyme Therapeutics HALO Q1 2026 Earnings EPS Beat Highlights Strong Operational Execution AGNCZ Q1 2026 Earnings Preferred EPS Surpasses Estimates by 145 HBANP Q1 2026 Earnings EPS Misses Estimates by 2345 Despite Positive Stock Reaction MED Q1 2026 Earnings EPS Surprises Significantly Despite Negative Results